Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Double Blind Clinical Trial of the Efficacy, Effect on Gametocytes and Tolerability of Amodiaquine Vs Amodiaquine Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Quibdo, Colombia

NCT00378625 is registered in ClinicalTrials.gov with Centro Internacional de Entrenamiento e Investigaciones Médicas as lead sponsor.

NCT NCT00378625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00378625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Double Blind Clinical Trial of the Efficacy, Effect on Gametocytes and Tolerability of Amodiaquine Vs Amodiaquine Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Quibdo, Colombia
Lead sponsor
Centro Internacional de Entrenamiento e Investigaciones Médicas
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2000
Completion date
March 31, 2006
Enrollment
360
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antimalarials, malaria, malaria,falciparum